Contact
Attralus Bulletin
News, Press Releases, & Other Media
About Amyloidosis
Amyloidosis
Science & Pipeline
Leadership
TEam
Bulletin
Contact
all posts
All Posts
Press Releases
Press Releases
In the News
In the News
Note: Attralus, Inc. was formally known as Aurora Bio, Inc.
In the News
September 14, 2020
Attralus Eyes Further Work on Therapeutic Candidates with New Funding
www.biospace.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
www.biospace.com
In the News
September 14, 2020
Attralus Raises $25 Million to Transform Treatment for Patients with Systemic Amyloidosis
globalgenes.org
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
globalgenes.org
In the News
September 14, 2020
The Crunchbase News Briefing: Mon., Sept. 14
news.crunchbase.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
news.crunchbase.com
In the News
September 14, 2020
Attralus Raises $25M in Series A Financing
finsmes.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
finsmes.com
In the News
September 14, 2020
Attralus Secures $25M Series A to Diagnose and Treat Amyloidosis
timmermanreport.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
timmermanreport.com
In the News
September 14, 2020
Attralus debuts with $25M series A to tackle systemic amyloidosis
biocentury.com
Note: Source article is behind a pay wall
Note: Source article is only available to members, but subscription is free
Read More
Read on
biocentury.com
Get in Touch
Partnership, Careers, Press, OR PATIENT Inquiries
VIEW OUR CURRENT JOB OPENINGS
Name*
COMPANY
Email*
PHONE
sUBJECT*
Message*
Thank you
Your message has been received!
We will reply as soon as possible.
Oops! Something went wrong while submitting the form.
our apologies
TABLET & MOBILE EXPERIENCES
ARE STILL UNDER CONSTRUCTION
Please view on a desktop or laptop computer.
